Global Dry Eye Drugs Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

SKU ID : QYR- 18342060

Publishing Date : 27-May-2021

No. of pages : 110

PRICE
5600
8400
11200

  • Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
    The classification of Dry Eye Drugs includes Artificial Tears, Anti-inflammatory drugs and other, and the proportion of Artificial Tears in 2017 is about 89%.

    In 2020, the global Dry Eye Drugs market size was US$ 8579.5 million and is forecast to 16930 million US in 2027, growing at a CAGR of 12.0% during the 2021-2027. In this study, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Dry Eye Drugs.
    The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Dry Eye Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Dry Eye Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Dry Eye Drugs market. Readers of the report can become informed about current and future trends of the global Dry Eye Drugs market and how they will impact market growth during the forecast period.

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Segment by Type
    Artificial Tears
    Anti-inflammatory Drugs
    Other

    Segment by Application
    Hospital
    Drug Stores
    Online Pharmacies

    By Company
    Allergan
    Novartis AG
    Bausch Health
    Santen Pharma
    Takeda
    Johnson & Johnson
    United Laboratories
    Senju Pharmaceutical
    Jianfeng Group
    Eusan GMBH

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports